Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hypertension

  Free Subscription


Articles published in Curr Opin Nephrol Hypertens

Retrieve available abstracts of 29 articles:
HTML format



Single Articles


    December 2020
  1. LI J, Raizada MK, Richards EM
    Gut-brain-bone marrow axis in hypertension.
    Curr Opin Nephrol Hypertens. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  2. BASILE DP, Abais-Battad JM, Mattson DL
    Contribution of Th17 cells to tissue injury in hypertension.
    Curr Opin Nephrol Hypertens. 2020;Publish Ahead of Print.
    PubMed     Abstract available


    November 2020
  3. BOSCH A, Schmieder RE
    Novel approaches to management of hypertension.
    Curr Opin Nephrol Hypertens. 2020 Nov 12. doi: 10.1097/MNH.0000000000000668.
    PubMed     Abstract available


    July 2020
  4. LU X, Crowley SD
    Actions of immune cells in the hypertensive kidney.
    Curr Opin Nephrol Hypertens. 2020 Jul 20. doi: 10.1097/MNH.0000000000000635.
    PubMed     Abstract available


  5. EDMONSTON DL, Sparks MA
    Therapeutic options for chronic kidney disease-associated pulmonary hypertension.
    Curr Opin Nephrol Hypertens. 2020 Jul 9. doi: 10.1097/MNH.0000000000000624.
    PubMed     Abstract available


    May 2020
  6. WEN Y, Crowley SD
    The varying roles of macrophages in kidney injury and repair.
    Curr Opin Nephrol Hypertens. 2020;29:286-292.
    PubMed     Abstract available


    March 2020
  7. GUERROT D, Humalda JK
    Blood pressure targets in chronic kidney disease: an update on the evidence.
    Curr Opin Nephrol Hypertens. 2020 Mar 9. doi: 10.1097/MNH.0000000000000601.
    PubMed     Abstract available


  8. CURTIS S, Komenda P
    Screening for chronic kidney disease: moving toward more sustainable health care.
    Curr Opin Nephrol Hypertens. 2020 Mar 5. doi: 10.1097/MNH.0000000000000597.
    PubMed     Abstract available


  9. REN L, Colafella KMM, Bovee DM, Uijl E, et al
    Targeting angiotensinogen with RNA-based therapeutics.
    Curr Opin Nephrol Hypertens. 2020;29:180-189.
    PubMed     Abstract available


  10. HINRICHS GR, Jensen BL, Svenningsen P
    Mechanisms of sodium retention in nephrotic syndrome.
    Curr Opin Nephrol Hypertens. 2020;29:207-212.
    PubMed     Abstract available


    December 2019
  11. KOKENY G, Calvier L, Legchenko E, Chouvarine P, et al
    PPARgamma is a gatekeeper for extracellular matrix and vascular cell homeostasis: beneficial role in pulmonary hypertension and renal/cardiac/pulmonary fibrosis.
    Curr Opin Nephrol Hypertens. 2019 Dec 5. doi: 10.1097/MNH.0000000000000580.
    PubMed     Abstract available


    November 2019
  12. FANG S, Sigmund CD
    PPARgamma and RhoBTB1 in hypertension.
    Curr Opin Nephrol Hypertens. 2019 Nov 27. doi: 10.1097/MNH.0000000000000579.
    PubMed     Abstract available


    August 2019
  13. LUM EL, Bunnapradist S
    Current opinions in nephrology and hypertension: kidney transplantation in patients with plasma cell dyscrasias.
    Curr Opin Nephrol Hypertens. 2019 Aug 8. doi: 10.1097/MNH.0000000000000544.
    PubMed     Abstract available


    July 2019
  14. CACERES PS, Ortiz PA
    Molecular regulation of NKCC2 in blood pressure control and hypertension.
    Curr Opin Nephrol Hypertens. 2019 Jul 15. doi: 10.1097/MNH.0000000000000531.
    PubMed     Abstract available


  15. DASGUPTA I, Sharp ASP
    Renal sympathetic denervation for treatment of hypertension: where are we now in 2019?
    Curr Opin Nephrol Hypertens. 2019 Jul 1. doi: 10.1097/MNH.0000000000000532.
    PubMed     Abstract available


    May 2019
  16. ROEHM B, Weiner DE
    Blood pressure targets and kidney and cardiovascular disease: same data but discordant guidelines.
    Curr Opin Nephrol Hypertens. 2019;28:245-250.
    PubMed     Abstract available


    April 2019
  17. PARK SH, Zhang Y, Rogers JA, Gallon L, et al
    Recent advances of biosensors for hypertension and nephrology.
    Curr Opin Nephrol Hypertens. 2019 Apr 30. doi: 10.1097/MNH.0000000000000517.
    PubMed     Abstract available


    March 2019
  18. KIM HK, Mizuno M, Vongpatanasin W
    Phosphate, the forgotten mineral in hypertension.
    Curr Opin Nephrol Hypertens. 2019 Mar 14. doi: 10.1097/MNH.0000000000000503.
    PubMed     Abstract available


  19. MUTCHLER SM, Kleyman TR
    New insights regarding epithelial Na+ channel regulation and its role in the kidney, immune system and vasculature.
    Curr Opin Nephrol Hypertens. 2019;28:113-119.
    PubMed     Abstract available


  20. JAMA HA, Kaye DM, Marques FZ
    The gut microbiota and blood pressure in experimental models.
    Curr Opin Nephrol Hypertens. 2019;28:97-104.
    PubMed     Abstract available


    May 2018
  21. HOU J, Nast CC
    Changing concepts of HIV infection and renal disease.
    Curr Opin Nephrol Hypertens. 2018;27:144-152.
    PubMed     Abstract available


    February 2018
  22. RECKELHOFF JF
    Gender differences in hypertension.
    Curr Opin Nephrol Hypertens. 2018 Feb 5. doi: 10.1097/MNH.0000000000000404.
    PubMed     Abstract available


    December 2017
  23. KURTZ TW, DiCarlo SE, Pravenec M, Morris RC Jr, et al
    The pivotal role of renal vasodysfunction in salt sensitivity and the initiation of salt-induced hypertension.
    Curr Opin Nephrol Hypertens. 2017 Dec 22. doi: 10.1097/MNH.0000000000000394.
    PubMed     Abstract available


    November 2017
  24. WEN Y, Crowley SD
    Renal effects of cytokines in hypertension.
    Curr Opin Nephrol Hypertens. 2017 Nov 14. doi: 10.1097/MNH.0000000000000385.
    PubMed     Abstract available


    October 2017
  25. KAPIL V, Sobotka PA, Lobo MD, Schmieder RE, et al
    Central arteriovenous anastomosis to treat resistant hypertension.
    Curr Opin Nephrol Hypertens. 2017 Oct 27. doi: 10.1097/MNH.0000000000000379.
    PubMed     Abstract available


    August 2017
  26. GEORGIANOS PI, Agarwal R
    Blood pressure in hemodialysis: targets?
    Curr Opin Nephrol Hypertens. 2017 Aug 21. doi: 10.1097/MNH.0000000000000359.
    PubMed     Abstract available


    April 2017
  27. VAN BUREN PN
    Pathophysiology and implications of intradialytic hypertension.
    Curr Opin Nephrol Hypertens. 2017 Apr 8. doi: 10.1097/MNH.0000000000000334.
    PubMed     Abstract available


    March 2017
  28. HSU RK, Powe NR
    Recent trends in the prevalence of chronic kidney disease: not the same old song.
    Curr Opin Nephrol Hypertens. 2017 Mar 17. doi: 10.1097/MNH.0000000000000315.
    PubMed     Abstract available


    February 2017
  29. RUZICKA M, Hiremath S
    Intensive blood pressure lowering in chronic kidney disease: the time has come.
    Curr Opin Nephrol Hypertens. 2017 Feb 13. doi: 10.1097/MNH.0000000000000316.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: